M&A Deal Summary

Full-Life Acquires Focus-X

On November 28, 2022, Full-Life acquired life science company Focus-X

Acquisition Highlights
  • This is Full-Life’s 1st transaction in the Life Science sector.
  • This is Full-Life’s 1st transaction in the United States.
  • This is Full-Life’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2022-11-28
Target Focus-X
Sector Life Science
Buyer(s) Full-Life
Deal Type Add-on Acquisition

Target

Focus-X

Watchung, New Jersey, United States
Focus-X is a preclinical-stage biotechnology company committed to the discovery and development of cutting-edge radiopharmaceuticals. Focus-X was founded in 2020 and is based in Watchung, New Jersey.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Full-Life

China
Category Company
Founded 2021
Sector Life Science
DESCRIPTION

Full-Life is a fully integrated global radiopharmaceutical company with operations in Europe and China. We seek to own the entire value chain for radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients. Full-Life was founded in 2021 and is based in Shanghai, China.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Mergr

Product

Company

Legal